TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from CardieX ( (AU:CDX) ).
CardieX Limited has announced a change in the interests of its director, Niall Cairns, with the acquisition of additional shares through an Entitlement Offer. This move reflects a significant increase in Cairns’ holdings across multiple entities, potentially strengthening his influence within the company. The acquisition of shares at a discounted rate may indicate confidence in the company’s future prospects and could impact its market positioning and stakeholder interests.
More about CardieX
CardieX Limited operates in the health technology industry, focusing on the development and commercialization of medical devices and digital solutions for cardiovascular health management. The company is known for its innovative products that aim to improve patient outcomes and provide valuable insights into heart health.
Average Trading Volume: 273,017
Technical Sentiment Signal: Sell
Current Market Cap: A$22M
Learn more about CDX stock on TipRanks’ Stock Analysis page.